Vitenskapelig artikkel

• André Rudolph; Johannes Mofors; A. Frisk et al. (2026). Patterns of migration underlie the increasing incidence of Kawasaki disease in Sweden from 1987 to 2018: a cohort study. (ekstern lenke)
• Ahmed Sayadi; Johanna K. Sandling; Maija Leena Eloranta et al. (2025). Rare and common single nucleotide variants in childhood-onset systemic lupus erythematosus. (ekstern lenke)
• María Bueno Álvez; Sofia Bergström; Josefin Kenrick et al. (2025). A human pan-disease blood atlas of the circulating proteome. (ekstern lenke)
• Albin Björk; Johannes Mofors; Lauro Meneghel et al. (2025). A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren’s disease. (ekstern lenke)
• Sven-Erik Sonesson; Aurelie Ambrosi; Felicia Nordenstam et al. (2024). Impact of early detection and steroid treatment on fetal ventricular heart rate and pacemaker implantation in anti-Ro/SSA positive congenital heart block. (ekstern lenke)
• M. Ivanchenko; Gudny Ella Thorlacius; Malin Hedlund et al. (2021). Natural killer cells and type II interferon in Ro/SSA and La/SSB autoantibody-exposed newborns at risk of congenital heart block. (ekstern lenke)
• Christian Lundtoft; Christopher Sjöwall; Solbritt Rantapää-Dahlqvist et al. (2022). Strong association of combined genetic deficiencies in the classical complement pathway with risk of systemic lupus erythematosus and primary Sjögren's syndrome. (ekstern lenke)
• Johannes Mofors; Albin Björk; Elina Richardsdotter Andersson et al. (2020). Cigarette smoking patterns preceding primary Sjögren's syndrome. (ekstern lenke)
• Christian Lundtoft; Pascal Pucholt; Myriam Martin et al. (2022). Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases. (ekstern lenke)
• Sabrina Meisgen; Malin Hedlund; Aurelie Ambrosi et al. (2022). Auxilin is a novel susceptibility gene for congenital heart block which directly impacts fetal heart function. (ekstern lenke)
• Javier Rodríguez-Carrio; Agata Burska; Philip G Conaghan et al. (2023). 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice. (ekstern lenke)
• Agata Burska; Javier Rodríguez-Carrio; Robert Biesen et al. (2023). Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. (ekstern lenke)
• Cecilia Fugmann; Sarah Reid; Pascal Pucholt et al. (2024). A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease. (ekstern lenke)
• Aurelie Ambrosi; Gudny Ella Thorlacius; Sven-Erik Sonesson et al. (2021). Interferons and innate immune activation in autoimmune congenital heart block. (ekstern lenke)
• Johannes Mofors; André Rudolph; Bodil Schiller et al. (2025). Associations of infection burden with Kawasaki disease in a population-based setting during 30 years. (ekstern lenke)
• Bhuwan Khatri; Kandice L. Tessneer; Astrid Rasmussen et al. (2022). Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells. (ekstern lenke)
• Mandi M. Wiley; Marcin Radziszewski; Bhuwan Khatri et al. (2025). Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland. (ekstern lenke)
• Albin Björk; Rui Da Silva Rodrigues; Elina Richardsdotter Andersson et al. (2021). Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment. (ekstern lenke)
• Javier Rodríguez-Carrio; Agata Burska; P.G. Conaghan et al. (2023). Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. (ekstern lenke)
• Matteo Bianchi; Sergey V. Kozyrev; Antonella Notarnicola et al. (2024). Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases. (ekstern lenke)
• Yu Gao; Ruining Liu; Chenfei He et al. (2021). SOCS3 Expression by Thymic Stromal Cells Is Required for Normal T Cell Development. (ekstern lenke)
• Charlotta Preger; Antonella Notarnicola; Cecilia Hellström et al. (2023). Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies. (ekstern lenke)
• Valérie Leclair; Angeles S. Galindo-Feria; Simon Rothwell et al. (2023). Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies. (ekstern lenke)
• Andrea Scheffschick; Julia Nenonen; Mengmeng Xiang et al. (2023). Skin infiltrating NK cells in cutaneous T-cell lymphoma are increased in number and display phenotypic alterations partially driven by the tumor. (ekstern lenke)
• Angeles S. Galindo-Feria; Karin Lodin; Begum Horuluoglu et al. (2025). Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Simon J. Bowman; Raphaele Seror; Raphael Porcher et al. (2025). Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI). (ekstern lenke)
• Manuel Ramos-Casals; Alan N. Baer; María del Pilar Brito-Zerón et al. (2025). 2023 International Rome consensus for the nomenclature of Sjögren disease. (ekstern lenke)
• Gudny Ella Thorlacius; Albin Björk; Marie Elisabeth Wahren Herlenius (2023). Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies. (ekstern lenke)

Fagartikkel

• Raphaèle Seror; Gabriel Baron; Marine Camus et al. (2022). Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome. (ekstern lenke)

Rettelse i tidsskrift

• Bhuwan Khatri; Kandice L. Tessneer; Astrid Rasmussen et al. (2023). Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (Nature Communications, (2022), 13, 1, (4287), 10.1038/s41467-022-30773-y). (ekstern lenke)
• Bhuwan Khatri; Kandice L. Tessneer; Astrid Rasmussen et al. (2022). Erratum: Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells (Nature communications (2022) 13 1 (4287)). (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.